Best Supplements for Reduced Gastrointestinal Symptoms
Ranked by research evidence. Compare 31 supplements across 42 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- Low evidence3 studies
Across 3 studies, all reported beneficial effects on reduced gastrointestinal symptoms, with effect sizes ranging from small to moderate (predominantly moderate). However, no studies reported statistically significant findings. The evidence is drawn from review articles, primarily in athletic populations, with no specific dose or duration reported.
- Low evidence3 studies
Across 3 studies, all reported beneficial effects of Lactobacillus plantarum LP01 on reducing gastrointestinal symptoms, with moderate effect sizes observed in 2 studies and a small effect in 1. The most studied population was patients undergoing digestive surgery or bowel preparation, with one study showing significant symptom reduction at a dose of 1 billion living cells/day. Evidence is preliminary due to the small number of studies.
Dose: 1 billion living cells/day - Low evidence3 studies
Across 3 review studies, all reported moderate beneficial effects of Bifidobacterium plantarum-containing probiotics on reducing gastrointestinal symptoms. Evidence comes from general populations, CKD patients, and athletes, but no consistent dose, duration, or form data were available. The predominant effect size is moderate, but the evidence base is limited.
- LowBifidobacterium animalis subsp. lactis LAFTI B94Across 3 studies, all reported beneficial effects on reduced gastrointestinal symptoms, with effect sizes ranging from small to moderate (predominantly moderate). However, no studies reported statistically significant findings. The evidence is drawn from review articles, primarily in athletic populations, with no specific dose or duration reported.3 beneficial3 studies
- LowLactobacillus plantarum LP01Across 3 studies, all reported beneficial effects of Lactobacillus plantarum LP01 on reducing gastrointestinal symptoms, with moderate effect sizes observed in 2 studies and a small effect in 1. The most studied population was patients undergoing digestive surgery or bowel preparation, with one study showing significant symptom reduction at a dose of 1 billion living cells/day. Evidence is preliminary due to the small number of studies. · Dose: 1 billion living cells/day3 beneficial3 studies
- LowBifidobacterium plantarumAcross 3 review studies, all reported moderate beneficial effects of Bifidobacterium plantarum-containing probiotics on reducing gastrointestinal symptoms. Evidence comes from general populations, CKD patients, and athletes, but no consistent dose, duration, or form data were available. The predominant effect size is moderate, but the evidence base is limited.3 beneficial3 studies
- LowLactobacillus helveticus L10Across 3 studies, 2 reported moderate beneficial effects of Lactobacillus helveticus L10 on reducing gastrointestinal symptoms, while 1 neutral study found no difference. The evidence predominantly points toward a moderate beneficial effect, though the sample is small and no studies reached statistical significance. Most data comes from physically active or athletic populations, and doses and study durations were not consistently reported.2 beneficial1 neutral3 studies